Intercure (IC0) AI Stock Analysis

Intercure

(Stuttgart:IC0)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Revenue RecoveryThe return to revenue growth indicates improving demand and commercial execution after two weaker years. If maintained, renewed sales momentum can support greater operating scale, strengthen the company’s position across cultivation, manufacturing and dispensing, and provide a foundation for future profit recovery.

Negative Factors

Persistent Net LossesContinued net losses show that the recent revenue recovery has not yet translated into sustainable profitability. Persistent losses can constrain reinvestment, weaken retained equity over time and make the business more dependent on disciplined cost control and continued improvement in sales economics.

Intercure Business Overview & Revenue Model

Company Description

InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to prod...

Intercure Peers Comparison

Overall Rating

Financial Indicators

DE:IC0 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

DE:IC0 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IL:TGTR	Together Pharma Ltd.	189.90	-127.50	-40.17%
IL:CNZN.M	Canzon-M	89.90	-11.90	-11.69%
IL:SEMG	Seach Medical Group Ltd.	257.60	-4.96	-1.89%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Intercure AI Stock Analysis